AU2003273803A1 - Use of triptans as antiviral agents - Google Patents

Use of triptans as antiviral agents

Info

Publication number
AU2003273803A1
AU2003273803A1 AU2003273803A AU2003273803A AU2003273803A1 AU 2003273803 A1 AU2003273803 A1 AU 2003273803A1 AU 2003273803 A AU2003273803 A AU 2003273803A AU 2003273803 A AU2003273803 A AU 2003273803A AU 2003273803 A1 AU2003273803 A1 AU 2003273803A1
Authority
AU
Australia
Prior art keywords
triptans
antiviral agents
antiviral
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003273803A
Inventor
Antonio Cassar Scalia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003273803A1 publication Critical patent/AU2003273803A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
AU2003273803A 2002-08-28 2003-08-26 Use of triptans as antiviral agents Abandoned AU2003273803A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2002A001860 2002-08-28
IT001860A ITMI20021860A1 (en) 2002-08-28 2002-08-28 USE OF TRIPTANS AS ANTI-VIRAL AGENTS.
PCT/EP2003/009435 WO2004019934A1 (en) 2002-08-28 2003-08-26 Use of triptans as antiviral agents

Publications (1)

Publication Number Publication Date
AU2003273803A1 true AU2003273803A1 (en) 2004-03-19

Family

ID=31972200

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003273803A Abandoned AU2003273803A1 (en) 2002-08-28 2003-08-26 Use of triptans as antiviral agents

Country Status (3)

Country Link
AU (1) AU2003273803A1 (en)
IT (1) ITMI20021860A1 (en)
WO (1) WO2004019934A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103601683B (en) * 2010-04-16 2016-03-30 中国科学院上海药物研究所 Benzo-heterocycle compound and its production and use
CN104436197A (en) 2011-10-21 2015-03-25 艾伯维公司 Combined product of at least two direct acting antiviral agents
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
JP5677645B2 (en) 2011-10-21 2015-02-25 アッヴィ・インコーポレイテッド At least two direct acting antiviral agents and a method for treating HCV comprising ribavirin but not interferon
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
EP3448392A4 (en) 2016-04-28 2020-01-15 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto
US11400136B2 (en) * 2017-06-19 2022-08-02 President And Fellows Of Harvard College Methods and compositions for treating a microbial infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2880595A (en) * 1994-07-06 1996-01-25 Bo Arne Hofmann Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses

Also Published As

Publication number Publication date
ITMI20021860A1 (en) 2004-02-29
WO2004019934A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
AU2003209285A1 (en) Deazapurine nucleoside analogs and their use as therapeutic agents
AU2003209400A1 (en) Multiple degree of freedom interferometer
AU2003224725A1 (en) Hiv therapeutic
AU2003218758A1 (en) Derivatives of 1-phenyl-3-phenylpyrazole as herbicides
AU2003269092A1 (en) Computation of contour
AU2003249909A1 (en) Phenoxypropenylphenyl derivatives and their use as herbicides
AU2003221256A1 (en) Use of bcma as an immunoregulatory agent
AU2003236991A1 (en) Representations of processes
AU2003235280A1 (en) Honeycomb structural body
AU2003293723A1 (en) 3-pyrrolyl urea derivatives and their use as antiviral agents
AU2003287666A1 (en) Systemic delivery of antiviral agents
AU2003244836A1 (en) Suspending agent
AU2003231947A1 (en) Defensins: use as antiviral agents
AU2003299100A1 (en) Pyrimidine compounds as therapeutic agents
AU2003215676A1 (en) Pyrazolopyrimidines derivatives
AU2003273803A1 (en) Use of triptans as antiviral agents
AU2003240437A1 (en) Use of dimethyl sulfone as isotonicity agent
AU2003290816A1 (en) Modified nucleosides as antiviral agents
AU2003242405A1 (en) Compounds and preparaitons having antiviral effect
AU2003267781A1 (en) Laser modification of complex objects
AU2003226725A1 (en) Pyrazolopyrimidine derivatives
AU2003269950A1 (en) Heteroaryl-ethanolamine derivatives as antiviral agents
AU2002952559A0 (en) New use
AU2003304151A1 (en) Heteroaryl-ethanolamine derivatives as antiviral agents
AU2003205963A1 (en) Azaphenylalanine derivatives and their use as antithrombotic agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase